Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Joincare Pharmaceutical Group Industry Co Ltd
600380Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products primarily in China. The company offers chemical preparation for drugs, including digestive tract, cardiovascular and cerebrovascular, antimicrobial, anti-tumor, assisted reproductive, neurological therapeutic, OCT, and other drugs; and traditional Chinese drug preparation production, which includes anti-tumor and cold products. It also provides chemical APIs and intermediates; diagnostic reagents and equipment; and health products under various brands, such as Taita, Jingxin, and Eagle's; and biologics include monoclonal antibodies, vaccines, recombinant therapeutic proteins, and other biological therapies. In addition, the company offers self-produced dietary supplement and medical devices. It offers its products in various forms, such as hormone tablets, oral liquids, and tablets. The company was founded in 1992 and is headquartered in Shenzhen, China. Address: Joincare Pharmaceutical Group Building, Shenzhen, China, 518057
Analytics
Zielpreis von Wall Street
98.94 CNYKGV
14.9359Dividendenrendite
–Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 600380
Dividenden-Analyse 600380
Dividendenwachstum über 5 Jahre
11 %Kontinuierliches Wachstum
1 JahrAusschüttungsquote 5-Jahres-Durchschnitt
25 %Verlauf der Dividende 600380
Bewertung der Aktie 600380
Finanzen 600380
Ergebnisse | 2019 | Dynamik |